Search

Mary T Didiuk

from Madison, CT
Age ~56
Get Report
Also known as:
Mary Dr Didiuk, Mary J Didiuk, Mark Didiuk, Mary K
Phone and address:
61 Hickory Ln, Madison, CT 06443
(860) 857-2214
Related to:
John Maraganore, 62
Connected to:
Josephine Didiuk, 85Oksana Didkovkiy, 56Caroline A Didlake, 34Nathan A Didlake, 40David A Didlot, 43Mark Didolci, 65Alex J Didomenico, 33Alexandra J Didomenico, 27Arthur J Didomenico, 80Courtney L Didomenico, 44

Mary Didiuk Phones & Addresses

  • 61 Hickory Ln, Madison, CT 06443 (860) 857-2214
  • 372 Meridian Street Ext, Groton, CT 06340 (860) 446-0622
  • 372 Meridian St, Groton, CT 06340 (860) 446-0622
  • 3 Rossie St, Mystic, CT 06355
  • 105 Oxford St, Cambridge, MA 02138 (617) 499-0049
  • Needham, MA
  • 372 Meridian Street Ext APT 49, Groton, CT 06340

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

Degree: Bachelor's degree or higher

Skills

Organic Synthesis • Synthetic Organic Chemistry • Chromatography • Drug Development • Drug Metabolism • Gpcrs • Adme • Drug Design • Drug Discovery • Lead Change • Chemistry • Medicinal Chemistry • Organic Chemistry • Nmr • Pharmaceutical Industry • Lifesciences • Parallel Synthesis • Cheminformatics • Hplc • Heterocyclic Chemistry • Biotechnology • Scifinder • Mass Spectrometry • Clinical Development • Lc Ms • Pharmaceutical Research • Purification • Biomarkers • Assay Development • Dmpk • High Throughput Screening • Pharmacology • In Vitro • Bioanalysis • Glp • High Performance Liquid Chromatography

Industries

Pharmaceuticals

Resumes

Resumes

Mary Didiuk Photo 1

Mary Didiuk

View page
Location:
61 Hickory Ln, Madison, CT 06443
Industry:
Pharmaceuticals
Skills:
Organic Synthesis
Synthetic Organic Chemistry
Chromatography
Drug Development
Drug Metabolism
Gpcrs
Adme
Drug Design
Drug Discovery
Lead Change
Chemistry
Medicinal Chemistry
Organic Chemistry
Nmr
Pharmaceutical Industry
Lifesciences
Parallel Synthesis
Cheminformatics
Hplc
Heterocyclic Chemistry
Biotechnology
Scifinder
Mass Spectrometry
Clinical Development
Lc Ms
Pharmaceutical Research
Purification
Biomarkers
Assay Development
Dmpk
High Throughput Screening
Pharmacology
In Vitro
Bioanalysis
Glp
High Performance Liquid Chromatography

Publications

Us Patents

Synthesis Of Compounds And Libraries Of Compounds

View page
US Patent:
7183059, Feb 27, 2007
Filed:
Sep 7, 2001
Appl. No.:
09/949280
Inventors:
Gregory L. Verdine - Lexington MA, US
Milan Chytil - Cambridge MA, US
Mary T. Didiuk - Mystic CT, US
Tiffany Malinky - Cambridge MA, US
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
G01N 33/53
C04B 1/00
US Classification:
435 71, 435 4, 435DIG 29, 530333, 564 12
Abstract:
A method of generating a compound having at least one biological activity of a peptide. The method includes identifying a biologically active peptide, providing a first monomer which contains terminal reactive moieties and at least one functionalizable group, providing a second monomer which contains terminal reactive moieties and at least one functionalizable group, and reacting first and second monomer under stereo-and/or regiochemically controlled conditions to yield a compound in which the monomers are attached by way of terminal reactive moieties.

Pyrido[4,3-]Pyrimidin-4(3)-One Derivatives As Calcium Receptor Antagonists

View page
US Patent:
7829572, Nov 9, 2010
Filed:
Oct 4, 2007
Appl. No.:
11/867255
Inventors:
Mary T. Didiuk - Madison CT, US
Kevin K. Liu - East Lyme CT, US
David A. Griffith - Old Saybrook CT, US
Angel Guzman-Perez - Mystic CT, US
Feng C. Bi - Groton CT, US
Daniel P. Walker - Chesterfield MO, US
Assignee:
Pfizer Inc - New York NY
International Classification:
C07D 471/00
A61K 31/519
A61P 3/14
A61P 19/02
US Classification:
5142641, 544279
Abstract:
The present invention is directed to novel pyrido[4,3-d]pyrimidin-4(3H)-one derivatives and pharmaceutically acceptable salts thereof of structural formula I.

Glucagon Receptor Modulators

View page
US Patent:
8507533, Aug 13, 2013
Filed:
Feb 7, 2012
Appl. No.:
13/367459
Inventors:
Gary Erik Aspnes - Rockville RI, US
Mary Theresa Didiuk - Madison CT, US
Kevin James Filipski - Ivoryton CT, US
Angel Guzman-Perez - Belmont MA, US
Esther Cheng Yin Lee - Mystic CT, US
Jeffrey Allen Pfefferkorn - Mystic CT, US
Benjamin Dawson Stevens - Manchester CT, US
Meihua Mike Tu - Mystic CT, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 31/415
C07D 231/12
US Classification:
514336, 548250, 514354, 514359
Abstract:
The present invention provides a compound of Formula (I).

Modulators Of Chemokine Receptor Activity

View page
US Patent:
20030008893, Jan 9, 2003
Filed:
Mar 6, 2002
Appl. No.:
10/093273
Inventors:
Roberto Colon-Cruz - Groton CT, US
Mary Didiuk - Groton CT, US
Erin Duffy - Deep River CT, US
Ravi Garigipati - South Glastonbury CT, US
Wan Lau - Noank CT, US
Wayne McDonald - East Lyme CT, US
International Classification:
A61K031/4745
A61K031/407
C07D471/02
US Classification:
514/300000, 514/412000, 546/113000, 548/453000
Abstract:
Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation are described herein.

Quinoline And Quinoxaline Compounds

View page
US Patent:
20040204450, Oct 14, 2004
Filed:
Mar 23, 2004
Appl. No.:
10/807838
Inventors:
Bruce Bechle - Oakdale CT, US
George Chang - Old Saybrook CT, US
Mary Didiuk - Groton CT, US
Jari Finneman - Salem CT, US
Ravi Garigipati - South Glastonbury CT, US
Ryan Kelley - Groton CT, US
David Perry - Mystic CT, US
Roger Ruggeri - Waterford CT, US
Assignee:
Pfizer Inc
International Classification:
A61K031/4709
C 07D 4 1/02
US Classification:
514/314000, 546/167000
Abstract:
Quinoline and quinoxaline compounds, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.

Modulators Of Chemokine Receptor Activity

View page
US Patent:
20050234090, Oct 20, 2005
Filed:
Nov 15, 2004
Appl. No.:
10/989764
Inventors:
Roberto Colon-Cruz - Groton CT, US
Mary Didiuk - Groton CT, US
Erin Duffy - Deep River CT, US
Ravi Garigipati - South Glastonbury CT, US
Wan Lau - Noank CT, US
Wayne McDonald - East Lyme CT, US
International Classification:
C07D471/02
A61K031/407
A61K031/4745
US Classification:
514300000, 514412000, 546113000, 548453000
Abstract:
Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation are described herein.

Quinoline Compounds

View page
US Patent:
20070149567, Jun 28, 2007
Filed:
Sep 12, 2005
Appl. No.:
10/576853
Inventors:
Mary Didiuk - Madison CT, US
Ryan Kelley - Groton CT, US
David Perry - Mystic CT, US
Roger Ruggeri - Waterford CT, US
Assignee:
Pfizer Inc - Groton CT
International Classification:
C07D 215/38
A61K 31/4706
US Classification:
514313000, 546159000
Abstract:
Quinoline compounds, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDLcholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.

Dibenzyl Amine Compounds And Derivatives

View page
US Patent:
20090239865, Sep 24, 2009
Filed:
Nov 21, 2005
Appl. No.:
11/719885
Inventors:
George Chang - Old Saybrook CT, US
Mary Didiuk - Madison CT, US
Peter Dorff - Griswold CT, US
Ravi Garigipati - South Glastonbury CT, US
Wenhua Jiao - Salem CT, US
Bruce Lefker - Gales Ferry CT, US
David Perry - Mystic CT, US
Roger Ruggeri - Waterford CT, US
Toby Underwood - Kent, GB
International Classification:
A61K 31/5377
C07D 257/06
A61K 31/41
A61K 31/4439
C07D 401/14
C07D 413/14
A61P 9/10
US Classification:
5142362, 548251, 514381, 514340, 5462684, 544140
Abstract:
Dibenzyl amine compounds and derivatives, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
Control profile
Mary T Didiuk from Madison, CT, age ~56 Get Report